Meet the Expert: Prof Ifeoma Okoye

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma

An oncologist's experience of managing breast cancer during the COVID-19 outbreak

COVID-19: What can be learned from Australia's approach

Tele health in providing psychological support to patients with cancer

The potential of KRAS inhibitors for non-small-cell lung cancer

Managing Hodgkin lymphoma during the COVID-19 outbreak

Meet the Expert: Dr Windy Dean-Colomb

Managing multiple myeloma during the COVID-19 outbreak

COVID-19: The situation in Peru and managing radiotherapy patients

Managing Hodgkin lymphoma in a COVID-19 world

How to mitigate stress in healthcare professionals during COVID-19